Fredun Pharmaceuticals Ltd - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1987.
1987 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Fredun Pharmaceuticals Ltd

Fredun Pharmaceuticals Ltd, a active public limited company, was established on 08 June 1987 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1987PLC043662. Registered under ROC Roc Mumbai. it is listed on BSE: 539730. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹5.37 Cr.

Formerly known as Fredun Pharmaceuticals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹349.07 Cr and a net worth of ₹121.47 Cr. Employing 388 professional, Its leadership includes Daisy Dsouza (Director), Daulat Nariman Medhora (Whole-Time Director), Fredun Nariman Medhora (Managing Director). Past directors included Chandrakant Kanchanlal Shah, Nariman Bamansha Medhora, Ankita Kishor Joshi. It holds ₹245.38 Cr open charges and ₹136.27 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at 11Th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Mumbai, Maharashtra, 400013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24239MH1987PLC043662

  • Registration Number

    043662

  • Incorporation Date

    08 June 1987

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹5.37 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 539730)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 5.37 Cr
  • Company Age 38 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 245.38 Cr
  • Satisfied Charges ₹ 136.27 Cr
  • Revenue Growth **** 26.25%
  • Profit Growth **** 44.57%
  • Ebitda **** 36.74%
  • Net Worth 26.04%
  • Total Assets **** 19.56%
Company report

Fredun Pharmaceuticals Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Fredun Pharmaceuticals Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Fredun Pharmaceuticals Ltd?
Current Directors
Name Designation Appointment Date Status
Daisy Dsouza Director 24 Nov 2023 Current
Daulat Nariman Medhora Whole-Time Director 08 Jun 1987 Current
Fredun Nariman Medhora Managing Director 15 Sep 2006 Current
Anshu Gyan Agarwal Additional Director 30 Jul 2025 Current
Sonal Dharmin Desai Additional Director 30 Jul 2025 Current
Pooja Narendra Sanghavi Additional Director 28 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 Jul 2023 Past
Pramod Abcsdd Whole-Time Director 05 Jun 2021 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 03 Oct 2011 Past
Pramod Abcsdd Additional Director 17 Jan 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Fredun Pharmaceuticals.

Fredun Pharmaceuticals Ltd, for the financial year ended 2024, experienced significant growth in revenue, with a 26.25% increase. The company also saw a substantial improvement in profitability, with a 44.57% increase in profit. The company's net worth Soared by an impressive increase of 26.04%.

Fredun Pharmaceuticals revenue growth over time
Fredun Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 26.25%
*******
*******
*******
*******
Revenue from Operations
*******
 26.75%
*******
*******
*******
*******
Total Assets
*******
 19.56%
*******
*******
*******
*******
Profit or Loss
*******
 44.57%
*******
*******
*******
*******
Net Worth
*******
 26.04%
*******
*******
*******
*******
EBITDA
*******
 36.74%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Fredun Pharmaceuticals?

In 2024, Fredun Pharmaceuticals had a promoter holding of 49.17% and a public holding of 50.84%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,453,826,989.00

Satisfied Charges

₹1,362,674,893.00

Charges Breakdown by Lending Institutions
  • Others : 118.41 Cr
  • Hdfc Bank Limited : 84.50 Cr
  • State Bank Of India : 40.00 Cr
  • Yes Bank Limited : 1.28 Cr
  • Axis Bank Limited : 1.18 Cr
Latest Charge Details
Date Lender Amount Status
01 Oct 2025 Others ₹1.55 M Open
23 Sep 2025 Axis Bank Limited ₹2.49 M Open
23 Sep 2025 Axis Bank Limited ₹2.32 M Open
22 Sep 2025 Axis Bank Limited ₹7.00 M Open
04 Sep 2025 Others ₹2.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Fredun Pharmaceuticals?

Fredun Pharmaceuticals has a workforce of 388 employees as of Jan 08, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Fredun Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fredun Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Fredun Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Vaishnavi Rajkamal Sahu was appointed as a Company Secretary was appointed as a Company Secretary on 25 Dec 2025 & has been associated with this company since 1 month 16 days . was recorded as a recent event.

  • Director Appointment

    Pooja Narendra Sanghavi was appointed as a Additional Director was appointed as a Additional Director on 28 Nov 2025 & has been associated with this company since 2 months 15 days . was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 0.15 Cr with Charge ID 101193246 was registered on 01 Oct 2025. was completed.

  • Annual General Meeting

    Fredun Pharmaceuticals Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge with Axis Bank Limited amounted to Rs. 0.25 Cr with Charge ID 101171164 was registered on 23 Sep 2025. was documented.

  • Charges

    The activity A charge with Axis Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101171165 was registered on 23 Sep 2025. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Fredun Pharmaceuticals Ltd?

The CIN of Fredun Pharmaceuticals Ltd is L24239MH1987PLC043662.

Where is Fredun Pharmaceuticals Ltd headquartered?

Fredun Pharmaceuticals Ltd is headquartered at 11Th Floor, Tower A, Urmi Estate, 95, Ganpatrao Kadam Marg, Lower Parel (W), Mumbai, Maharashtra, 400013.

When was Fredun Pharmaceuticals Ltd incorporated?

Fredun Pharmaceuticals Ltd was incorporated on 08 June 1987.

Who are the current directors of Fredun Pharmaceuticals Ltd?

The current directors of Fredun Pharmaceuticals Ltd are

What is the primary industry of Fredun Pharmaceuticals Ltd?

The primary industry of Fredun Pharmaceuticals Ltd is Manufacturing.

Is Fredun Pharmaceuticals Ltd a listed company?

Fredun Pharmaceuticals Ltd is listed. It is listed on BSE: 539730.

What is the capital structure of Fredun Pharmaceuticals Ltd?

The authorized capital of Fredun Pharmaceuticals Ltd is ₹10.00 Cr, and the paid-up capital is ₹5.37 Cr.

What is the compliance status of Fredun Pharmaceuticals Ltd?

The compliance status of Fredun Pharmaceuticals Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available